Stanford University Medical Center

Site:	Stanford University Medical Center
Address:
City:	Palo Alto
State:	CA
Zip:	94304
Country:	USA

Phase	Trial	Trial Status	Site Status	Drug [asc]	NCT#
1	Study of the Glutaminase Inhibitor CB-839 in Solid Tumors	Active, not recruiting	Closed	CB-839	NCT02071862
1	A Phase 1b Study of MPDL3280A (an Engineered Anti-PDL1 Antibody) in Combination With Cobimetinib in Patients With Locally Advanced or Metastatic Solid Tumors	Ongoing, but not recruiting	Closed	Cobimetinib + MPDL3280A	NCT01988896
1/2	Study of the Safety, Pharmacokinetics and Efficacy of EDO-S101, in Patients With Advanced Solid Tumors	Completed	Closed	EDO-S101	NCT03345485
1	Phase 1 Trial of Hu5F9-G4, a CD47-targeting Antibody	Active, not recruiting	Closed	HuF9-G4	NCT02216409
2	Study of LOXO-101 in Subjects With NTRK Fusion Positive Solid Tumors	Active, not recruiting	Active, not recruiting	LOXO-101	NCT02576431
2	SARC029: Trametinib and Pazopanib in Patients With GIST (Gastrointestinal Stromal Tumor)	Withdrawn	Not yet activated	Pazopanib + Trametinib	NCT02342600
3	A Study of DCC-2618 vs Sunitinib in Advanced GIST Patients After Treatment With Imatinib (intrigue)	Active, not recruiting	Active	QINLOCK Ripretinib DCC-2618 SUTENT Sunitinib	NCT03673501
			Active